Neuropathology and pathogenesis in Alzheimer's disease (AD) and dementia are intricately linked to the progressive degeneration of brain tissue. AD is characterized by the accumulation of amyloid plaques and neurofibrillary tangles, leading to neuronal dysfunction and eventual cell death. Amyloid plaques primarily consist of beta-amyloid peptides, while neurofibrillary tangles are aggregates of hyperphosphorylated tau protein. These pathological features disrupt neuronal communication and impair cognitive functions such as memory and reasoning.
The pathogenesis involves a complex interplay of genetic, environmental, and lifestyle factors, although the exact mechanisms are still under investigation. Neuroinflammation, oxidative stress, and mitochondrial dysfunction also contribute to disease progression. Understanding these neuropathological changes is crucial for developing targeted therapies aimed at halting or slowing the advancement of AD and related dementias, offering hope for improved quality of life and outcomes for affected individuals.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China